Drugs / Acyclovir
last change 10 days ago re-read 8 days ago

Acyclovir

Small molecule

Developed for
HIV infectious disease · herpes simplex infectious disease · herpes labialis · genital herpes · ulcer disease · chickenpox · herpes simplex virus keratitis · plantar wart
+17 more · substance abuse · common wart · cytomegalovirus infection · cytomegalovirus retinitis · genital herpes simplex type 2 infectious disorder · herpes simplex type 2 infectious disease · Herpesviridae infectious disease · Meniere disease · oral hairy leukoplakia · trigeminal neuralgia · uveitis · varicella zoster infection · viral pneumonia · facial paralysis · herpes zoster · molluscum contagiosum · viral meningitis
Investigated by
National Institute of Allergy and Infectious Diseases (NIAID) · Glaxo Wellcome · National Center for Research Resources (NCRR) · Centers for Disease Control and Prevention · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · Fred Hutchinson Cancer Center
+45 more · National Eye Institute (NEI) · University of Alabama at Birmingham · University of Washington · Assistance Publique - Hôpitaux de Paris · Bayer · Beijing Sanbo Brain Hospital · Beijing Tiantan Hospital · Bristol-Myers Squibb · Burroughs Wellcome · Cairo University · Comprehensive International Program of Research on AIDS · Food and Drug Administration (FDA) · French National Agency for Research on AIDS and Viral Hepatitis · GlaxoSmithKline · Hadassah Medical Organization · Institute for the Development of Africa · Jena University Hospital · King Edward Medical University · Kuwait Cancer Control Center · London School of Hygiene and Tropical Medicine · Meda Pharmaceuticals · Ministry of Health, Thailand · National Cancer Institute (NCI) · National Institute for Communicable Diseases, South Africa · National Institute for Health Research, United Kingdom · National Institute of Mental Health (NIMH) · National Institute on Drug Abuse (NIDA) · National Institutes of Health (NIH) · PT Pharma Metric Labs · PT. Kimia Farma (Persero) Tbk · Padagis LLC · Phillip Brian Smith · Riphah International University · TKL Research, Inc. · Tehran University of Medical Sciences · Transport Pharmaceuticals · University Hospital Birmingham NHS Foundation Trust · University Hospital, Toulouse · University of Maryland, Baltimore · University of North Carolina, Chapel Hill · University of Sao Paulo General Hospital · University of Utah · Valerio Therapeutics · Wake Forest University Health Sciences · Xiaomin Zhang

Regulatory milestones approvals, filings & regulatory actions · 7 recorded

MilestoneJurisdictionBrandIndicationDateSentence it was read from
Filed herpes labialis 1 milestone
Filed EU (EMA) Sitavig herpes labialis —

“the submission of a European registration dossier for Sitavir®/Sitavig® are particularly key milestones” valeriotx.com ↗

Approved Indication not stated 2 milestones
Label expansions (5) US (FDA) ZOVIRAX — 1989-12-22 – 1998-06-02 fda.gov ↗
Approved US (FDA) ZOVIRAX — 1982-03-29 fda.gov ↗

Trials 52

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 14 trials
Phase 1 NCT05589688 Apr 2024 → Dec 2026 expected obesity disorder University Hospital, Toulouse Recruiting No outcome recorded
Phase 1 NCT00942084 Sep 2011 → Jun 2012 herpes simplex infectious disease, neonatal sepsis Phillip Brian Smith Completed No outcome recorded
Phase 1 NCT01010698 Jun 2009 → Dec 2012 — University of Maryland, Baltimore Completed No outcome recorded
Phase 1 NCT00001010 ? → Oct 1990 HIV infectious disease National Institute of Allergy and Infectious Diseases (NIAID) Completed No outcome recorded
Phase 1/21 trial
Phase 1/2 NCT00004644 Feb 1995 → ? herpes simplex infectious disease National Center for Research Resources (NCRR) Completed No outcome recorded
Phase 27 trials · 1 met primary · 1 missed
Phase 2 NCT06558838 Aug 2024 → Nov 2025 herpes labialis University of Utah Completed No outcome recorded
Phase 2 NCT01503918 Jan 2012 → Jan 2014 — University Hospital Birmingham NHS Foundation Trust Completed Met primary
Phase 2 NCT00469300 Apr → Sep 2007 herpes labialis Transport Pharmaceuticals Completed No outcome recorded
Phase 2 NCT00371592 Sep 2006 → Jan 2009 HIV infectious disease, herpes simplex type 2 infectious disease National Institute of Allergy and Infectious Diseases (NIAID) Completed No outcome recorded
Phase 2 NCT00158483 May 2003 → Oct 2005 genital herpes, ulcer disease French National Agency for Research on AIDS and Viral Hepatitis Completed Missed primary
Phase 2 NCT00000712 ? → Nov 1994 HIV infectious disease National Institute of Allergy and Infectious Diseases (NIAID) Completed No outcome recorded
Phase 2 NCT00000953 ? → Sep 1996 HIV infectious disease, chickenpox National Institute of Allergy and Infectious Diseases (NIAID) Completed No outcome recorded
Phase 2/34 trials
Phase 2/3 NCT06261684 Oct 2023 → Oct 2024 plantar wart Cairo University Unknown No outcome recorded
Phase 2/3 NCT01729767 Aug 2011 → Dec 2012 Meniere disease Tehran University of Medical Sciences Unknown No outcome recorded
Phase 2/3 NCT00164424 Mar 2005 → Mar 2009 HIV infectious disease, herpes simplex infectious disease, ulcer disease Centers for Disease Control and Prevention Completed No outcome recorded
Phase 2/3 NCT00209313 Mar 2005 → Apr 2007 HIV infectious disease Fred Hutchinson Cancer Center Completed No outcome recorded
Phase 318 trials · 3 met primary · 2 missed
Phase 3 NCT06134492 Feb 2024 → Jul 2026 overdue herpes simplex infectious disease, viral pneumonia Jena University Hospital Recruiting No outcome recorded
Phase 3 NCT05098938 Nov 2021 → Jul 2023 herpes labialis Bayer Completed Missed primary
Phase 3 NCT03656965 May 2018 → May 2021 substance abuse Kuwait Cancer Control Center Unknown No outcome recorded
Phase 3 NCT02265913 Oct 2014 → Apr 2016 herpes labialis Padagis LLC Completed No outcome recorded
Phase 3 NCT01574612 Mar → Dec 2012 herpes labialis Meda Pharmaceuticals Completed No outcome recorded
Phase 3 NCT00855309 Nov 2008 → Nov 2013 herpes simplex infectious disease Wake Forest University Health Sciences Completed No outcome recorded
Phase 3 NCT00769314 May 2007 → Nov 2008 herpes labialis Valerio Therapeutics Completed Met primary
Phase 3 NCT00076232 Apr 2005 → Jun 2007 HIV infectious disease, genital herpes National Institute of Allergy and Infectious Diseases (NIAID) Completed Missed primary
Phase 3 NCT00031447 Aug 1999 → Feb 2008 herpes simplex infectious disease National Institute of Allergy and Infectious Diseases (NIAID) Completed No outcome recorded
Phase 3 NCT00031460 Dec 1997 → Feb 2008 herpes simplex infectious disease National Institute of Allergy and Infectious Diseases (NIAID) Completed Met primary
Phase 46 trials · 1 missed
Phase 4 NCT07448844 Feb → May 2026 overdue common wart, plantar wart Riphah International University Recruiting No outcome recorded
Phase 4 NCT03831165 Sep 2015 → Sep 2021 genital herpes University of Sao Paulo General Hospital Completed No outcome recorded
Phase 4 NCT00527618 Dec 2007 → Mar 2011 HIV infectious disease, genital herpes simplex type 2 infectious disorder University of Washington Completed Mixed
Phase 4 NCT00362297 Sep 2006 → Dec 2008 genital herpes University of Washington Completed Missed primary
Phase 4 NCT00362596 Jan → Aug 2005 HIV infectious disease, herpes simplex infectious disease Centers for Disease Control and Prevention Completed No outcome recorded
Phase 4 NCT00467662 — herpes labialis Hadassah Medical Organization Unknown No outcome recorded
Phase not applicable12 trials
— NCT07673549 Aug 2026 → Dec 2027 expected trigeminal neuralgia Beijing Tiantan Hospital Not yet recruiting No outcome recorded
— NCT06217406 Mar 2024 → Mar 2027 expected — Assistance Publique - Hôpitaux de Paris Not yet recruiting No outcome recorded
— NCT04988646 Feb → Apr 2020 substance abuse PT. Kimia Farma (Persero) Tbk Completed No outcome recorded
— NCT06380647 Oct 2019 → Sep 2020 Herpesviridae infectious disease King Edward Medical University Completed No outcome recorded
— NCT03389191 Jan 2017 → Dec 2019 uveitis Xiaomin Zhang Unknown No outcome recorded
— NCT02053142 Jan → Dec 2009 ulcer disease University of North Carolina, Chapel Hill Completed No outcome recorded
— NCT00001115 ? → Jun 2005 HIV infectious disease, herpes simplex infectious disease National Institute of Allergy and Infectious Diseases (NIAID) Completed No outcome recorded
— NCT00002290 — HIV infectious disease Glaxo Wellcome Completed No outcome recorded
— NCT00002026 — HIV infectious disease, oral hairy leukoplakia Glaxo Wellcome Completed No outcome recorded
— NCT00000693 ? → Mar 1992 HIV infectious disease, cytomegalovirus retinitis National Institute of Allergy and Infectious Diseases (NIAID) Completed No outcome recorded
Comparator or background therapy51 trials
Phase 0 NCT03457025 Background Aug 2019 → Jun 2020 Bell's palsy NYU Langone Health Withdrawn No outcome recorded Stop: Enrollment
Phase 1 NCT03178149 Background Jul 2018 → Dec 2027 expected age-related macular degeneration Astellas Institute for Regenerative Medicine Recruiting No outcome recorded
Phase 1 NCT02977533 Background Dec 2016 → May 2018 multiple sclerosis Sanofi Completed No outcome recorded
Phase 1 NCT02583594 Background Dec 2015 → Mar 2016 multiple sclerosis Genzyme, a Sanofi Company Completed No outcome recorded
Phase 1 NCT02282826 Background Oct 2014 → Mar 2016 multiple sclerosis Genzyme, a Sanofi Company Completed No outcome recorded

News releases announcing trial results or a regulatory action · 8

DateIssuerRelease
2024-01-01 Alembic Pharmaceuticals Ltd. Regulatory Press Release USFDA Products Approvals For the Qtr ended 31st Dec, 2023 alembicpharmaceuticals.com ↗
2023-03-02 Zydus Lifesciences Limited Regulatory Zydus receives final approval from the USFDA for Acyclovir Cream zyduslife.com ↗
Zydus Lifesciences Limited (including its subsidiaries/affiliates, hereafter referred to as “Zydus”) has received final approval from the United States Food and Drug Administration (USFDA) for Acyclovir Cream, 5% (USRLD: Zovirax® Cream).
2020-11-11 Impax Laboratories, LLC Regulatory Amneal Receives Abbreviated New Drug Application Approval for Acyclovir Cream, 5% amneal.com ↗
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal”) today announced that it has received approval for its Abbreviated New Drug Application (ANDA) from the U.S. Food and Drug Administration (FDA) for Acyclovir Cream, 5%.
2019-03-19 Zydus Lifesciences Limited Regulatory Zydus receives final approval from the USFDA for Acyclovir Ointment zyduslife.com ↗
Zydus Cadila has received the final approval from the USFDA to market Acyclovir Ointment USP (US RLD – Zovirax ®), 5%.
2019-02-06 Perrigo Company Regulatory Perrigo Announces FDA Final Approval for its AB Rated Generic Version of Zovirax® Cream 5% perrigo.com ↗
Perrigo Company plc (NYSE; TASE: PRGO) today announced it has received final approval from the U.S. Food and Drug Administration for its AB rated Abbreviated New Drug Application referencing Zovirax® Cream, 5% (acyclovir cream, 5%) developed in collaboration with Sol-Gel Technologies Ltd. (NASDAQ: SLGL).
2014-03-19 Valerio Therapeutics Regulatory Sitavig® Licensing Strategy: Execution of licensing agreement with Innocutis for North America and Positive opinion from French and German Health Authorities for Marketing Authorization valeriotx.com ↗
In Europe, the Company received a positive opinion from the Health Authorities in France and Germany for the Market Authorization of the drug.
2010-10-26 Medivir Results Medivir’s U.S. commercialisation partner Meda presents positive Xerese™ data at the AOA's Osteopathic Medical Conference and Exposition medivir.com ↗
The study found that the combination was well tolerated and had a favourable safety profile.
2008-03-19 Medivir Results Lipsovir® prevents cold sores. Phase III clinical trial results first to show prevention by early treatment. medivir.com ↗
Treatment with Lipsovir® prevented the development of cold sores in 42% of patients.

All press releases naming this drug 12 releases

DateIssuerRelease

Evidence & citations 40 cited values

Every value below carries the sentence it was read from. 107 sources stand behind the page.

FieldValueCited text
Known as Acyclovir “Bacterial or Viral infection treatment may include: Doxycycline, Minocycline, Nitazoxanide, Hydroxychloroquine, Rifampin, Dapsone, Azithromycin, Tetracycline, Benzathine...” NCT05894954 ↗
96

“standard treatment for herpes zoster which include acyclovir 800 mg, 5 times daily administered orally within the first 72 hours” NCT04656821 ↗

“In case of history of zoster or fungal infection a prophylaxis with Acyclovir or Diflucan should be also considered.” NCT01042704 ↗

“routine medical treatment of post herpetic neuralgia as controls (Pregabalin, acyclovir, and paracetamol)” NCT04546334 ↗

“All patients will receive antiviral therapy in the form of acyclovir,valcyclovir” NCT05112354 ↗

“Acyclovir prophylaxis during velcade administration” NCT01114048 ↗

“acyclovir 400mg: one pill 4 times daily for 7 days” NCT03457025 ↗

“Acyclovir (ACV)” NCT03443869 ↗

NCT02583594 ↗

NCT00808405 ↗

NCT00000953 ↗

Show 86 more sources

Known as aciclovir “Acyclovir (aciclovir) is a nucleoside antiviral drug with antiviral activity in vitro against members of the herpes group of DNA viruses.” PMID 2653790 ↗ Mar 1989
6

“We investigated the effect of daily suppressive aciclovir on HIV-1 disease progression in Rakai, Uganda.” PMID 22433279 ↗ Mar 2012

NCT01327144 ↗

NCT01503918 ↗

NCT01281007 ↗

NCT02152358 ↗

NCT02205489 ↗

Known as Aciclovir sodium ChEMBL registry synonym — accepted as the source's own label CHEMBL184 ↗
Known as Aciclovirum ChEMBL registry synonym — accepted as the source's own label CHEMBL184 ↗
Known as ACV “OBJECTIVES: I. Determine whether acyclovir (ACV) oral suspension suppresses recurrent skin lesions and improves neurologic outcome in neonates with localized herpes simplex...” NCT00004757 ↗
10

“To study the use of acyclovir (ACV) and zidovudine (AZT) in the treatment of cytomegalovirus (CMV) retinitis in patients with AIDS who would otherwise be treated with...” NCT00000693 ↗

“Earlier studies during the era of zidovudine (Retrovir) monotherapy showed a survival advantage when acyclovir (ACV, Zovirax) was added to the treatment of patients with HIV.” NCT00405821 ↗

“Part A: To evaluate the impact of HSV suppression with acyclovir ( ACV ) on HIV burden in patients with asymptomatic HSV infection and at high risk for HSV reactivation.” NCT00001115 ↗

“three separate phase III trials of acyclovir (ACV) for prevention of HIV-1 acquisition and transmission” PMID 20702659 ↗ Aug 2010

“Treatment and Suppression of Hairy Leukoplakia in ARC Patients With Oral Acyclovir (ACV)” NCT00002026 ↗

“concurrent oral Retrovir / Zovirax (AZT and ACV) therapy and oral AZT therapy alone” NCT00002290 ↗

“Acyclovir (ACV)” NCT07341386 ↗

“Acyclovir (ACV)” NCT00158483 ↗

“Acyclovir (ACV)” NCT03443869 ↗

“acyclovir (ACV)” NCT00000712 ↗

Known as Acycloguanosine ChEMBL registry synonym — accepted as the source's own label CHEMBL184 ↗
Known as Acyclovir component of xerese ChEMBL registry synonym — accepted as the source's own label CHEMBL184 ↗
Known as ACYCLOVIR SODIUM ChEMBL registry synonym — accepted as the source's own label CHEMBL184 ↗
Known as Acyclovir sodium salt ChEMBL registry synonym — accepted as the source's own label CHEMBL184 ↗
Known as Avaclyr ChEMBL registry synonym — accepted as the source's own label CHEMBL184 ↗
Known as Avert ChEMBL registry synonym — accepted as the source's own label CHEMBL184 ↗
Known as BAYM008894 “Acyclovir 50mg buccal/topical tablet, BAYM008894/UI1614773” NCT05098938 ↗
Known as BW 248U ChEMBL registry synonym — accepted as the source's own label CHEMBL184 ↗
Known as BW 248U SODIUM ChEMBL registry synonym — accepted as the source's own label CHEMBL184 ↗
Known as Clearsore ChEMBL registry synonym — accepted as the source's own label CHEMBL184 ↗
Known as Cymex ultra ChEMBL registry synonym — accepted as the source's own label CHEMBL184 ↗
Known as Duvimex ChEMBL registry synonym — accepted as the source's own label CHEMBL184 ↗
Known as Gerpevir ChEMBL registry synonym — accepted as the source's own label CHEMBL184 ↗
Known as Herpetad ChEMBL registry synonym — accepted as the source's own label CHEMBL184 ↗
Known as Lipsore ChEMBL registry synonym — accepted as the source's own label CHEMBL184 ↗
Known as Lypsyl ChEMBL registry synonym — accepted as the source's own label CHEMBL184 ↗
Known as Novirus ChEMBL registry synonym — accepted as the source's own label CHEMBL184 ↗
Known as NSC-645011 ChEMBL registry synonym — accepted as the source's own label CHEMBL184 ↗
Known as NSC-758477 ChEMBL registry synonym — accepted as the source's own label CHEMBL184 ↗
Known as Ranovir ChEMBL registry synonym — accepted as the source's own label CHEMBL184 ↗